arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Sana Biotechnology, Inc.

SANA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.85
Today
as of Sep 4, 16:54 ET
Last 30 days +17.38% Jul 27 → Sep 04
$3.05 $3.35 $3.64 $3.94 $4.24 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$3.86
High
$3.92
Low
$3.81
Volume
$1M
Avg Vol
$4M
Mkt Cap
$1.1B
P/E (TTM)
—
Beta
—
52w High
$6.55
52w Low
$2.61
Div Yield
—
Shares Out
$299M

Recent Press Releases & News last 60 days · 7 items

Sep 1 · 20:05 PR GlobeNewswire
Sana Biotechnology to Present at September 2026 Investor Conferences
Aug 10 · 20:15 MT Newswires
Sana Biotechnology Q2 Adjusted Loss Narrows
Aug 10 · 20:12 Associated Press
Sana: Q2 Earnings Snapshot
▸ Show all 7 press releases & news Free account →

Overview

52-week range
$2.61
$6.55
31% of range
Avg surprise (last 3)
+11.9%
Avg reaction (last 2)
+3.9%
100% positive
Latest IV / EM
229%
EM ±35.7% · $5 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.59$-0.48$-0.36$-0.25$-0.14 Actual $-0.43Actual $-0.59Actual $-0.49Actual $-0.21Actual $-0.25Actual $-0.20Est $-0.22Actual $-0.16Est $-0.20Actual $-0.16Actual $-0.14Est $-0.15Actual $-0.22 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-94M$-81M$-69M$-57M$-44M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.22 — — — — financials
Mon May 11, 2026Mar/2026 $-0.14 $-0.15 +6.7% +30.0% +1.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.16 — — — — financials
Mon Aug 11, 2025Jun/2025 $-0.16 $-0.20 +20.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.20 $-0.22 +9.1% — +6.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.21 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.49 — — — — financials
Sat Sep 30, 2023Sep 2023 — — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.59 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-65M$-49M—$-44M$-95M$-51M—$-62M
Net income$-64M$-47M—$-42M$-94M$-49M—$-60M
EPS (diluted)$-0.22$-0.17—$-0.16$-0.39$-0.21—$-0.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$57M$84M$72M$103M$71M$96M$128M$127M
Inventory————————
Total current assets$171M$112M$149M$162M$83M$113M$161M$210M
Total assets$432M$374M$417M$435M$362M$445M$501M$559M
Long-term debt————————
Total liabilities$277M$254M$256M$240M$239M$236M$251M$267M
Total equity$155M$119M$161M$195M$123M$209M$251M$292M

Implied volatility — last 90 days

101%469%838%1206%1575% Jun 08 — IV 212% · EM ±28.0%Jun 09 — IV 241% · EM ±30.1%Jun 10 — IV 165% · EM ±19.5%Jun 11 — IV 291% · EM ±32.1%Jun 12 — IV 310% · EM ±31.7%Jun 15 — IV 243% · EM ±17.5%Jun 17 — IV 1264% · EM ±52.8%Jun 19 — IV 136% · EM ±30.2%Jun 22 — IV 139% · EM ±29.0%Jun 23 — IV 212% · EM ±43.3%Jun 24 — IV 245% · EM ±49.1%Jun 25 — IV 236% · EM ±46.2%Jun 26 — IV 298% · EM ±57.0%Jun 29 — IV 270% · EM ±47.8%Jun 30 — IV 292% · EM ±50.4%Jul 01 — IV 311% · EM ±52.0%Jul 02 — IV 338% · EM ±54.7%Jul 03 — IV 351% · EM ±54.9%Jul 06 — IV 177% · EM ±24.6%Jul 07 — IV 198% · EM ±26.2%Jul 08 — IV 260% · EM ±32.6%Jul 09 — IV 452% · EM ±53.4%Jul 10 — IV 594% · EM ±65.7%Jul 13 — IV 756% · EM ±63.2%Jul 14 — IV 852% · EM ±61.6%Jul 15 — IV 978% · EM ±57.7%Jul 16 — IV 906% · EM ±37.9%Jul 20 — IV 101% · EM ±23.9%Jul 21 — IV 140% · EM ±32.4%Jul 22 — IV 135% · EM ±31.0%Jul 23 — IV 222% · EM ±49.8%Jul 24 — IV 228% · EM ±50.3%Jul 27 — IV 248% · EM ±51.8%Jul 28 — IV 282% · EM ±57.8%Jul 29 — IV 247% · EM ±49.4%Jul 30 — IV 236% · EM ±46.2%Jul 31 — IV 284% · EM ±54.3%Aug 03 — IV 248% · EM ±44.0%Aug 04 — IV 305% · EM ±52.5%Aug 05 — IV 358% · EM ±59.8%Aug 06 — IV 363% · EM ±58.7%Aug 07 — IV 364% · EM ±56.8%Aug 10 — IV 440% · EM ±60.9%Aug 11 — IV 498% · EM ±65.8%Aug 12 — IV 521% · EM ±65.3%Aug 13 — IV 554% · EM ±65.4%Aug 14 — IV 510% · EM ±56.3%Aug 17 — IV 610% · EM ±50.9%Aug 18 — IV 724% · EM ±52.3%Aug 19 — IV 1032% · EM ±60.9%Aug 20 — IV 1575% · EM ±65.8%Aug 24 — IV 190% · EM ±39.7%Aug 25 — IV 151% · EM ±30.8%Aug 26 — IV 143% · EM ±28.6%Aug 27 — IV 153% · EM ±29.9%Aug 28 — IV 158% · EM ±30.3%Aug 31 — IV 197% · EM ±34.9%Sep 01 — IV 224% · EM ±38.5%Sep 02 — IV 189% · EM ±31.5%Sep 03 — IV 201% · EM ±32.5%Sep 04 — IV 229% · EM ±35.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in